Effectiveness of autoHYpnosis in the Prevention of Anxiety During Radiotherapy of Head and Neck Tumors (HYMACO)

Sponsor
Institut de Cancérologie de Lorraine (Other)
Overall Status
Recruiting
CT.gov ID
NCT04671485
Collaborator
(none)
60
2
3
25.5
30
1.2

Study Details

Study Description

Brief Summary

HYMACO is a monocentric, randomized comparative pilot study with a total duration of 25 months. The purpose of this study is to evaluate the effectiveness of autoHYpnosis by anchoring in the prevention of anxiety related to wearing the mask for radiotherapy of head and neck tumors.

60 patients will be randomized into 3 arms ARM A : Standard care ARM B : Autohypnosis ARM C : Musicotherapy This study is carried out during the first 5 radiotherapy sessions because this is decisive for the good progress of subsequent sessions

Condition or Disease Intervention/Treatment Phase
  • Other: Standard care
  • Other: Autohypnosis
  • Other: Musicotherapy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Randomized, Comparative Pilot Study Evaluating the Effectiveness of autoHYpnosis by Anchoring in the Prevention of Anxiety Related to Wearing the Mask for Radiotherapy of Head and Neck Tumors
Actual Study Start Date :
Dec 16, 2020
Anticipated Primary Completion Date :
Jan 30, 2023
Anticipated Study Completion Date :
Jan 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: ARM A : standard care

standard care : Patient undergoing radiotherapy for head and neck tumor with a compression mask, and assessed as anxious about wearing this mask will have standard care

Other: Standard care
Patient undergoing radiotherapy for head and neck tumor with a compression mask, and assessed as anxious about wearing this mask will have standard care

Active Comparator: ARM B : standard care + Autohypnosis

In addition to the standard care, the patient will be called to learn autohypnosis during a specific consultation, with a radiotherapy manipulator trained to learn this technic. The patient will use this technic during the centering scanner and the first 5 radiotherapy sessions

Other: Standard care
Patient undergoing radiotherapy for head and neck tumor with a compression mask, and assessed as anxious about wearing this mask will have standard care

Other: Autohypnosis
The patient will be called to learn autohypnosis during a specific consultation, with a radiotherapy manipulator trained to learn this technic. The patient will use this technic during the centering scanner and the first 5 radiotherapy sessions

Active Comparator: ARM C : standard care + Musicotherapy

In addition to the standard care, the patient will choose the music he want to listen from a music database (3 specific moods). The chosen music will be broadcast to the patient via a hi-fi system present in the treatment room during the centering scanner and for the first 5 radiotherapy sessions

Other: Standard care
Patient undergoing radiotherapy for head and neck tumor with a compression mask, and assessed as anxious about wearing this mask will have standard care

Other: Musicotherapy
the patient will choose the music he want to listen from a music database (3 specific moods). The chosen music will be broadcast to the patient via a hi-fi system present in the treatment room during the centering scanner and for the first 5 radiotherapy sessions

Outcome Measures

Primary Outcome Measures

  1. Anxiety [5 weeks]

    Anxiety will be assessed by the maximum value obtained on the STAI form Y-A questionnaire (state anxiety) on the following 3 measurements: on the centering scanner, at the first and 5th radiotherapy session.

Secondary Outcome Measures

  1. Anxiety [5 weeks]

    Anxiety will also be assessed by a digital rating scale (0 to 10), in the centering or radiotherapy scanner room, just before making the mask before the centering scan and before fitting the mask before each of the first five radiotherapy sessions

  2. Conduct of radiotherapy session [5 weeks]

    The good conduct of the centering scanner and radiotherapy session is determined by: no interruption of the session the absence of vocal intervention by the manipulator during the session

  3. Time required by the hypnopractor for the hypnosis session [1 hour]

    The duration of the conditioning hypnosis session will be collected by the hypnopractor manipulator

  4. Receptivity of patients to hypnosis [5 weeks]

    Corresponds to the time difference in minutes between the actual time of making and wearing the compression mask for the centering scanner and wearing a compression mask for the first 5 radiotherapy sessions and the time estimated by the patient

  5. Assessment of the patient's feelings [1 hour]

    The patient's feelings will be evaluate a questionnaire composed of 5 questions already used in a previous study

  6. Hypnopractic manipulator's satisfaction with the ease of performing the conditioning hypnosis [1 hour]

    Assesing by the hypnopractor manipulator at the end of the session using a digital rating scale (0 to 10).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age > or =18

  • Patient to receive radiotherapy for a tumor of the head and neck, with a compression mask

  • Patient who obtained a score equal to or greater than 56 on the STAI form Y-A questionnaire during the consultation with the radiotherapist before starting treatment

  • Patient capable and willing to follow all study procedures in accordance with the protocol

  • Patient who understood the study and gave informed consent

  • Patient affiliated to a social security system

Exclusion Criteria:
  • Contraindication to hypnosis: psychosis, schizophrenia

  • Non-French speaking patient

  • Significant hearing loss

  • Pregnant woman, likely to be, or breastfeeding

  • Persons deprived of their liberty or under guardianship (including guardianship)

  • Inability to undergo medical monitoring of the trial for geographical, social or psychological reasons

  • Patient who has already received radiotherapy to the head or neck with a compression mask

Contacts and Locations

Locations

Site City State Country Postal Code
1 Institut de Cancérologie de Lorraine Vandoeuvre les nancy France 54519
2 Institut de Cancérologie de Lorraine Vandœuvre-lès-Nancy France Vandoeuvre lès Nancy

Sponsors and Collaborators

  • Institut de Cancérologie de Lorraine

Investigators

  • Study Chair: Rémi ETIENNE, Institut de Cancérologie de Lorraine
  • Principal Investigator: RENARD Sophie, MD, Institut de Cancérologie de Lorraine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Institut de Cancérologie de Lorraine
ClinicalTrials.gov Identifier:
NCT04671485
Other Study ID Numbers:
  • 2020-A00813-36
First Posted:
Dec 17, 2020
Last Update Posted:
Mar 24, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Institut de Cancérologie de Lorraine
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 24, 2022